AYTU: Lake Street Takes Role as Sole Book-Running Manager | AYTU Stock News - GuruFocus
2 days ago • Google News
Aytu BioScience Inc (AYTU)
US$ 1.64-9.65%
Price Chart
Key Statistics
Market Cap
$ 9.81M
P/E Ratio
0.00
Revenue (TTM)
$ 77.69M
Volume
68.08K
52W High
$ 3.19
52W Low
$ 0.95
Dividend Yield
0.00%
Beta
-0.10
Technicals
50-Day MA
1.3704
200-Day MA
1.7185
52 Week High
3.19
52 Week Low
0.95
About AYTU
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.
Employees
102
Headquarters
Denver, CO
CEO
Mr. Joshua R. Disbrow
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg